Literature DB >> 19015231

Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression.

Mark A Frye1, Gerhard Helleman, Susan L McElroy, Lori L Altshuler, David O Black, Paul E Keck, Willem A Nolen, Ralph Kupka, Gabriele S Leverich, Heinz Grunze, Jim Mintz, Robert M Post, Trisha Suppes.   

Abstract

OBJECTIVE: Treatment-emergent mania can have substantial negative impact on overall mood and psychosocial stability in patients receiving treatment for bipolar depression. This study examined the correlates associated with treatment-emergent mania in patients receiving adjunctive antidepressant treatment for bipolar depression.
METHOD: A total of 176 adult outpatients with bipolar disorder in a 10-week trial of adjunctive antidepressant treatment for depression were categorized into three groups based on the Clinical Global Impression Scale for Bipolar Disorder: those who responded to antidepressant treatment (N=85), those who did not respond to antidepressant treatment (N=45), and those who had treatment-emergent mania or hypomania (N=46). Symptom severity was measured with the Inventory of Depressive Symptomatology and the Young Mania Rating Scale (YMRS) at baseline and bimonthly intervals. Factor analysis was used to examine correlates of treatment-emergent mania.
RESULTS: Baseline YMRS scores were significantly different between groups. Otherwise, there were no significant between-group differences in demographic or clinical characteristics. Factor analysis showed that a subset of the YMRS items predicted treatment-emergent mania in this sample: increased motor activity, speech, and language-thought disorder.
CONCLUSIONS: These data suggest that minimal manic symptoms at baseline coexisting with otherwise full syndromal bipolar depression are associated with antidepressant treatment-emergent mania or hypomania. A careful examination of motor activation, pressured speech, and racing thoughts is warranted before starting antidepressant treatment in bipolar depression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19015231     DOI: 10.1176/appi.ajp.2008.08030322

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  32 in total

1.  Prevalence and clinical significance of subsyndromal manic symptoms, including irritability and psychomotor agitation, during bipolar major depressive episodes.

Authors:  Lewis L Judd; Pamela J Schettler; Hagop Akiskal; William Coryell; Jan Fawcett; Jess G Fiedorowicz; David A Solomon; Martin B Keller
Journal:  J Affect Disord       Date:  2012-02-06       Impact factor: 4.839

2.  Broadening bipolar diagnostic criteria: why not start with hypomania?

Authors:  Susan L McElroy
Journal:  World Psychiatry       Date:  2011-10       Impact factor: 49.548

Review 3.  Clinical staging in the pathophysiology of psychotic and affective disorders: facilitation of prognosis and treatment.

Authors:  Trevor Archer; Richard M Kostrzewa; Tomas Palomo; Richard J Beninger
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

4.  The complexity of "mixed" depression: a common clinical presentation.

Authors:  Steven D Targum; Andrew Nierenberg
Journal:  Innov Clin Neurosci       Date:  2011-06

Review 5.  Review of pharmacological treatment in mood disorders and future directions for drug development.

Authors:  Xiaohua Li; Mark A Frye; Richard C Shelton
Journal:  Neuropsychopharmacology       Date:  2011-09-07       Impact factor: 7.853

Review 6.  Chronobiological Therapy for Mood Disorders.

Authors:  Sara Dallaspezia; Masahiro Suzuki; Francesco Benedetti
Journal:  Curr Psychiatry Rep       Date:  2015-12       Impact factor: 5.285

Review 7.  Treatment of Mixed Features in Bipolar Disorder: an Updated View.

Authors:  Trisha Chakrabarty; Kamyar Keramatian; Lakshmi N Yatham
Journal:  Curr Psychiatry Rep       Date:  2020-02-06       Impact factor: 5.285

8.  Influence of an interaction between lithium salts and a functional polymorphism in SLC1A2 on the history of illness in bipolar disorder.

Authors:  Sara Dallaspezia; Sara Poletti; Cristina Lorenzi; Adele Pirovano; Cristina Colombo; Francesco Benedetti
Journal:  Mol Diagn Ther       Date:  2012-10       Impact factor: 4.074

9.  High level of persistence of pediatric bipolar-I disorder from childhood onto adolescent years: a four year prospective longitudinal follow-up study.

Authors:  Janet Wozniak; Carter R Petty; Meghan Schreck; Alana Moses; Stephen V Faraone; Joseph Biederman
Journal:  J Psychiatr Res       Date:  2011-06-17       Impact factor: 4.791

10.  Evidence-based definitions of bipolar-I and bipolar-II disorders among 5,635 patients with major depressive episodes in the Bridge Study: validity and comorbidity.

Authors:  J Angst; A Gamma; C L Bowden; J M Azorin; G Perugi; E Vieta; A H Young
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-01-31       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.